During the past decade, FXB Rwanda conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "FXB Rwanda" #1 collaborator was "Echidna Giving" with 1 trials as a collaborator, "FXB" with 1 trials as a collaborator, "Grand Challenges Canada" with 1 trials as a collaborator, "InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company" with 1 trials as a collaborator and "LEGO" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "FXB Rwanda" are "Child Development" (1 trials), "Child Development, Social Protection" (1 trials), "Child Malnutrition" (1 trials), "Parent-Child Relations" (1 trials) and "Parenting" (1 trials). Many other conditions were trialed in "FXB Rwanda" in a lesser frequency.

Most popular intervention types in "FXB Rwanda" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sugira Muryango" (2 trials). Other intervention names were less common.

The vast majority of trials in "FXB Rwanda" are 2 trials for "All" genders.

Currently, there are NaN active trials in "FXB Rwanda". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in FXB Rwanda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in FXB Rwanda, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".